AAAAAA
Results: 1-25/28
Authors:
Riggs, JE
Ellis, BD
Hogg, JP
Al-Azzaz, A
Schochet, SS
Citation: Je. Riggs et al., Acute periaqueductal syndrome associated with the G11778A mitochondrial DNA mutation, NEUROLOGY, 56(4), 2001, pp. 570-571
Authors:
Riggs, JE
Walker, DB
Carroll, DL
Sun, YP
Citation: Je. Riggs et al., Optical limiting properties of suspended and solubilized carbon nanotubes, J PHYS CH B, 104(30), 2000, pp. 7071-7076
Authors:
Moudgil, SS
Riggs, JE
Citation: Ss. Moudgil et Je. Riggs, Fulminant peripheral neuropathy with severe quadriparesis associated with vincristine therapy, ANN PHARMAC, 34(10), 2000, pp. 1136-1138
Authors:
Sun, YP
Riggs, JE
Henbest, KB
Martin, RB
Citation: Yp. Sun et al., Nanomaterials as optical limiters, J NONLIN OP, 9(4), 2000, pp. 481-503
Authors:
Riggs, JE
Citation: Je. Riggs, The biphasic pattern of age-specific malignant brain tumor mortality rates, NEUROLOGY, 55(6), 2000, pp. 750-753
Authors:
Riggs, JE
Citation: Je. Riggs, The influence of smoking on the risk of Alzheimer's disease, NEUROLOGY, 54(3), 2000, pp. 777-778
Authors:
Nishino, I
Fu, J
Tanji, K
Yamada, T
Shimojo, S
Koori, T
Mora, M
Riggs, JE
Oh, SJ
Koga, Y
Sue, CM
Yamamoto, A
Murakami, N
Shanske, S
Byrne, E
Bonilla, E
Nonaka, I
DiMauro, S
Hirano, M
Citation: I. Nishino et al., Primary LAMP-2 deficiency causes X-linked vacuolar cardiomyopathy and myopathy (Danon disease), NATURE, 406(6798), 2000, pp. 906-910
Authors:
Riggs, JE
Hogg, JP
Citation: Je. Riggs et Jp. Hogg, Central pontine myelinolysis: Association with parenteral magnesium administration, MILIT MED, 165(6), 2000, pp. 494-495
Authors:
Riggs, JE
Moudgil, SS
Citation: Je. Riggs et Ss. Moudgil, Self-limited recurrent multifocal neurological symptoms, headache, and cerebrospinal fluid lymphocytic pleocytosis: A benign syndrome with a predilection for young adult men, MILIT MED, 165(2), 2000, pp. 160-161
Authors:
Hoeldtke, RD
Bryner, KD
Hobbs, GR
Horvath, GG
Riggs, JE
Christie, I
Ganser, G
Marcovina, SM
Lernmark, A
Citation: Rd. Hoeldtke et al., Antibodies to glutamic acid decarboxylase and peripheral nerve function intype 1 diabetes, J CLIN END, 85(9), 2000, pp. 3297-3308
Authors:
Riggs, JE
Sun, YP
Citation: Je. Riggs et Yp. Sun, Optical limiting properties of mono- and multiple-functionalized fullerenederivatives, J CHEM PHYS, 112(9), 2000, pp. 4221-4230
Authors:
Riggs, JE
Guo, ZX
Carroll, DL
Sun, YP
Citation: Je. Riggs et al., Strong luminescence of solubilized carbon nanotubes, J AM CHEM S, 122(24), 2000, pp. 5879-5880
Authors:
Sun, YP
Riggs, JE
Guo, ZX
Rollins, HW
Citation: Yp. Sun et al., Photoexcited state and electron transfer properties of fullerenes and related materials, OPTICAL AND ELECTRONIC PROPERTIES OF FULLERENES AND FULLERENE-BASED MATERIALS, 2000, pp. 43-81
Authors:
Sun, YP
Riggs, JE
Rollins, HW
Guduru, R
Citation: Yp. Sun et al., Strong optical limiting of silver-containing nanocrystalline particles in stable suspensions, J PHYS CH B, 103(1), 1999, pp. 77-82
Authors:
Riggs, JE
Sun, YP
Citation: Je. Riggs et Yp. Sun, Optical limiting properties of [60]fullerene and methano[60]fullerene derivative in solution versus in polymer matrix: The role of bimolecular processes and a consistent nonlinear absorption mechanism, J PHYS CH A, 103(4), 1999, pp. 485-495
Authors:
Sheth, RD
Riggs, JE
Citation: Rd. Sheth et Je. Riggs, Persistent occipital electrographic status epilepticus, J CHILD NEU, 14(5), 1999, pp. 334-336
Authors:
Riggs, JE
Mansmann, PT
Cook, LL
Schochet, SS
Hogg, JP
Citation: Je. Riggs et al., Fulminant CNS perivascular lymphocytic proliferation: Association with sargramostim, a hematopoietic growth factor, CLIN NEUROP, 22(5), 1999, pp. 288-291
Authors:
Riggs, JE
Schochet, SS
Citation: Je. Riggs et Ss. Schochet, Myotonia associated with sarcoidosis: Marked exacerbation with pravastatin, CLIN NEUROP, 22(3), 1999, pp. 180-181
Authors:
Sun, YP
Riggs, JE
Citation: Yp. Sun et Je. Riggs, Organic and inorganic optical limiting materials. From fullerenes to nanoparticles, INT R PH CH, 18(1), 1999, pp. 43-90
Authors:
Riggs, JE
Citation: Je. Riggs, Mortality cancer risk in parkinsonian patients: A population-based study, NEUROLOGY, 53(5), 1999, pp. 1158-1159
Authors:
Riggs, JE
Citation: Je. Riggs, Recombinant human nerve growth factor in the treatment of diabetic polyneuropathy, NEUROLOGY, 52(7), 1999, pp. 1517-1517
Authors:
Riggs, JE
Citation: Je. Riggs, Cost-effectiveness of tissue plasminogen activator for acute ischemic stroke, NEUROLOGY, 52(4), 1999, pp. 895-895
Authors:
Riggs, JE
Schochet, SS
Webb, RW
Citation: Je. Riggs et al., Exertional myalgia syndrome associated with diminished serum ammonia elevation in ischemic exercise testing, MILIT MED, 164(9), 1999, pp. 663-665
Authors:
Riggs, JE
Schochet, SS
Hogg, JP
Citation: Je. Riggs et al., Delayed diffuse upper motor neuron syndrome after compressive thoracic myelopathy, MILIT MED, 164(9), 1999, pp. 666-668
Authors:
Riggs, JE
Schochet, SS
Hogg, JP
Citation: Je. Riggs et al., Focal rhabdomyolysis and brachial plexopathy: An association with heroin and chronic ethanol use, MILIT MED, 164(3), 1999, pp. 228-229